يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Deore, U"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Corrigendum to Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival: [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024](S0923753421015532)(10.1016/j.annonc.2021.05.353)

    المؤلفون: Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De, Laurentiis M., Im, S., Petrakova, K., Valeria, Bianchi G., Martin, M., Nusch, A., Sonke, G.S., De, la Cruz-Merino L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

    المساهمون: Im, S.

    العلاقة: Annals of Oncology, Vol.32 No.10, pp.1307-1307; https://hdl.handle.net/10371/189537Test; 000709095000017; 2-s2.0-85112792663; 158588

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.07.011Test
    https://hdl.handle.net/10371/189537Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival.

    المؤلفون: Slamon, D J, Neven, P, Chia, S, JERUSALEM, Guy, De Laurentiis, M, Im, S, Petrakova, K, Valeria Bianchi, G, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Ji, Y, Wang, C, Deore, U, Chakravartty, A, Zarate, J P, Taran, T, Fasching, P A

    المصدر: Annals of Oncology, 32 (8), 1015-1024 (2021)

    مصطلحات موضوعية: CDK4/6 inhibitor, advanced breast cancer, overall survival, ribociclib, Aminopyridines, Purines, Receptors, Estrogen, Receptors, Progesterone, Fulvestrant, ERBB2 protein, human, Receptor, ErbB-2, Adolescent, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Double-Blind Method, Female, Humans, Postmenopause, Breast Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Hematology, Oncology, Human health sciences, Sciences de la santé humaine, Oncologie

    العلاقة: https://api.elsevier.com/content/article/PII:S0923753421015532?httpAccept=text/xmlTest; urn:issn:0923-7534; urn:issn:1569-8041

    الوصول الحر: https://orbi.uliege.be/handle/2268/292335Test

    View record in ORBi

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival

    المؤلفون: Slamon, D. J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Bianchi, G. Valeria, Martin, M., Nusch, A., Sonke, G. S., De la Cruz-Merino, L., Beck, J. T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J. P., Taran, T., Fasching, P. A.

    المساهمون: 임석아, Im, S.

    مصطلحات موضوعية: DEPENDENT KINASE 4/6, THERAPY, ribociclib, CDK4, 6 inhibitor, advanced breast cancer, overall survival

    العلاقة: Annals of Oncology, Vol.32 No.8, pp.1015-1024; 140901; https://hdl.handle.net/10371/177211Test; 000685036900010; 2-s2.0-85109796710

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.05.353Test
    https://hdl.handle.net/10371/177211Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024]. ; Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival’: [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024](S0923753421015532)(10.1016/j.annonc.2021.05.353)

    المؤلفون: Slamon, D J, Neven, P, Chia, S, Jerusalem, Guy, De Laurentiis, M, Im, S, Petrakova, K, Valeria Bianchi, G, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Ji, Y, Wang, C, Deore, U, Chakravartty, A, Zarate, J P, Taran, T, Fasching, P A

    المصدر: Annals of Oncology, 32 (10), 1307 (2021-10)

    مصطلحات موضوعية: Hematology, Oncology, Human health sciences, Sciences de la santé humaine, Oncologie

    العلاقة: https://api.elsevier.com/content/article/PII:S0923753421022092?httpAccept=text/xmlTest; urn:issn:0923-7534; urn:issn:1569-8041; https://orbi.uliege.be/handle/2268/300140Test; info:hdl:2268/300140; https://orbi.uliege.be/bitstream/2268/300140/1/PIIS0923753421022092.pdfTest; scopus-id:2-s2.0-85112792663; info:pmid:34412950

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.07.011Test
    https://orbi.uliege.be/handle/2268/300140Test
    https://orbi.uliege.be/bitstream/2268/300140/1/PIIS0923753421022092.pdfTest

    View record in BASE النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    232P Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC)

    المؤلفون: Yap, Y.S., Su, F., Joshi, M., Chiu, J., Masuda, N., Ito, Y., Ishikawa, T., Aruga, T., Kim, S.J., Deore, U., Babbar, N., Balbin, A.

    المساهمون: Eisai, Novartis, Novartis Pharmaceuticals Corporation

    المصدر: Annals of Oncology ; volume 32, page S459-S460 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.515Test
    https://api.elsevier.com/content/article/PII:S0923753421027447?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753421027447?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Development and characterization of sustained release microspheres by quasi emulsion solvent diffusion method

    المؤلفون: Deore B. V, Mahajan H. S, Deore U. V

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://sphinxsai.com/ctvol3/ct=42,hitendraTest mahajan (634-642).pdf.

    وصف الملف: application/pdf

    العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.623.9348Test; http://sphinxsai.com/ctvol3/ct=42,hitendraTest mahajan (634-642).pdf

    الإتاحة: http://sphinxsai.com/ctvol3/ct=42,hitendraTest mahajan (634-642).pdf

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Evaluation of anthelmintic activity of Ixora coccinea.

    المؤلفون: Surana, R., Aher, A. N., Pal, S. C., Deore, U. V.

    المصدر: International Journal of Pharmacy & Life Sciences; 2011, Vol. 2 Issue 6, p813-814, 2p

    مصطلحات موضوعية: RUBIACEAE, ANTHELMINTICS, PLANT extracts, ALBENDAZOLE, PARALYSIS, ANIMAL mortality, CHLOROFORM


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث